Literature DB >> 25370735

A difficulty in improving population survival outcome of gastric cancer in mainland China: low proportion of early diseases.

Xin-Zu Chen1, Wei-Han Zhang, Jian-Kun Hu.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25370735     DOI: 10.1007/s12032-014-0315-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  3 in total

1.  Epidemiological differences in haematological malignancies between Europe and China.

Authors:  Xin-Chuan Chen; Xin-Zu Chen
Journal:  Lancet Oncol       Date:  2014-10       Impact factor: 41.316

2.  Outcomes of surgical treatment for gastric cancer patients: 11-year experience of a Chinese high-volume hospital.

Authors:  Wei-Han Zhang; Xin-Zu Chen; Kai Liu; Xiao-Long Chen; Kun Yang; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Med Oncol       Date:  2014-08-12       Impact factor: 3.064

3.  High mortality from hepatic, gastric and esophageal cancers in mainland China: 40 years of experience and development.

Authors:  Rui Wang; Xin-Zu Chen
Journal:  Clin Res Hepatol Gastroenterol       Date:  2014-06-30       Impact factor: 2.947

  3 in total
  14 in total

1.  The thinking to the huge disease burden of gastric cancer in China and the increasing tendency of esophagogastric junctional adenocarcinoma.

Authors:  Kun Yang; Jian-Kun Hu
Journal:  Transl Gastroenterol Hepatol       Date:  2016-04-13

Review 2.  Gastric cancer treatment: similarity and difference between China and Korea.

Authors:  Kun Yang; Jian-Kun Hu
Journal:  Transl Gastroenterol Hepatol       Date:  2017-04-28

3.  Peritoneal Metastatic Cancer Stem Cells of Gastric Cancer with Partial Mesenchymal-Epithelial Transition and Enhanced Invasiveness in an Intraperitoneal Transplantation Model.

Authors:  Xiao-Hai Song; Xin-Zu Chen; Xiao-Long Chen; Kai Liu; Wei-Han Zhang; Xian-Ming Mo; Jian-Kun Hu
Journal:  Gastroenterol Res Pract       Date:  2020-08-05       Impact factor: 2.260

4.  Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations.

Authors:  Hong-Feng Gou; Yang Liu; Tian-Xia Yang; Cheng Zhou; Xin-Zu Chen
Journal:  Oncotarget       Date:  2017-01-03

5.  Low FAT4 expression is associated with a poor prognosis in gastric cancer patients.

Authors:  Xiaoting Jiang; Zhengchuang Liu; Yingjie Xia; Jungang Luo; Ji Xu; Xujun He; Houquan Tao
Journal:  Oncotarget       Date:  2017-12-26

6.  Upregulated RACK1 attenuates gastric cancer cell growth and epithelial-mesenchymal transition via suppressing Wnt/β-catenin signaling.

Authors:  Lihui Zhu; Wen Chen; Guoqing Li; Honghui Chen; Wenqiu Liao; Li Zhang; Xiaoli Xiao
Journal:  Onco Targets Ther       Date:  2019-06-20       Impact factor: 4.147

7.  Associations between gastric cancer risk and virus infection other than Epstein-Barr virus: The protocol of a systematic review and meta-analysis based on epidemiological studies.

Authors:  Rui Wang; Kai Liu; Xin-Zu Chen
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

8.  Strategies to improve treatment outcome in gastric cancer: a retrospective analysis of patients from two high-volume hospitals in Korea and China.

Authors:  Kun Yang; Yoon Young Choi; Wei-Han Zhang; Xin-Zu Chen; Mi Kyung Song; Jinae Lee; Bo Zhang; Zhi-Xin Chen; Hyoung-Il Kim; Jia-Ping Chen; Jae-Ho Cheong; Zong-Guang Zhou; Woo Jin Hyung; Jian-Kun Hu; Sung Hoon Noh
Journal:  Oncotarget       Date:  2016-07-12

9.  A Bottleneck in Understanding Metastatic Cancer Stem Cell of Peritoneal Seeding from Gastric Cancer: A Null Result in Brief.

Authors:  Xin-Zu Chen; Xiao-Hai Song; Xiao-Long Chen; Chang-Chun Li; Xian-Ming Mo; Jian-Kun Hu
Journal:  J Cancer       Date:  2017-09-16       Impact factor: 4.207

10.  Helicobacter pylori prevalence in the Southwest of China: A protocol for systematic review.

Authors:  Rui Wang; Dan Bai; Wen Xiang; Yu-Feng Zhang; Kun-Yi Ba; Xin-Zu Chen
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.